Paul Greengard

Paul Greengard
Public domain · source
Name	Paul Greengard
Birth date	December 11, 1925
Birth place	New York City, New York, U.S.
Death date	April 13, 2019
Death place	New York City, New York, U.S.
Nationality	American
Fields	Neuroscience, Pharmacology, Biochemistry
Institutions	Rockefeller University; Yale University; Columbia University; Brandeis University
Alma mater	Hamilton College; Columbia University; Johns Hopkins University
Known for	Signal transduction in the nervous system; discovery of DARPP-32; research on neurotransmitter regulation
Awards	Nobel Prize in Physiology or Medicine (2000); Albert Lasker Award; National Medal of Science

Paul Greengard was an American neuroscientist and pharmacologist whose work elucidated molecular mechanisms of signal transduction in neurons. He is best known for discoveries about phosphorylation cascades and the role of protein regulators in synaptic function, which influenced research in neuropharmacology, psychiatry, and neurodegenerative disease. His findings connected biochemical signaling to behavior and therapeutics used in neurology and psychiatry.

Early life and education

Born in New York City to immigrant parents, Greengard grew up in an environment influenced by the cultural centers of New York City, including exposure to institutions like Columbia University and communities in Manhattan. He attended Hamilton College where he developed interests that led him to pursue medicine at Columbia University College of Physicians and Surgeons and later focus on neuroscience at Johns Hopkins University and affiliated laboratories. During his formative years he interacted with scientists and clinicians from institutions such as Yale University School of Medicine and researchers connected to Rockefeller University, shaping his trajectory toward cellular neurobiology and biochemical pharmacology.

Research and scientific contributions

Greengard’s laboratory at Rockefeller University characterized intracellular signaling pathways by which neurotransmitters alter neuronal function, expanding upon work from contemporaries at Harvard University, Massachusetts Institute of Technology, and California Institute of Technology. He identified and characterized key phosphoproteins, including DARPP-32, linking dopaminergic signaling studied by groups at Stanford University and University of California, San Francisco to behavioral pharmacology investigated at Johns Hopkins University School of Medicine and University of Pennsylvania. His work on protein kinase A (PKA) substrates and phosphatases built on earlier biochemical frameworks from investigators at Max Planck Society laboratories and complemented discoveries by researchers at Cold Spring Harbor Laboratory and Salk Institute for Biological Studies.

By elucidating how cyclic AMP-dependent pathways modulate ion channels and receptors—concepts also pursued at University of California, Los Angeles and University College London—Greengard connected molecular events to synaptic plasticity, learning, and memory research linked to groups at Princeton University and Columbia University. He collaborated with neuroscientists studying neurotransmitter systems such as dopamine and glutamate investigated at Karolinska Institute and University of Oxford. His investigations influenced therapeutic approaches for disorders researched at National Institutes of Health, including Parkinson’s disease studies at Mount Sinai Hospital and schizophrenia investigations at Yale University.

Greengard’s techniques included biochemical purification, phosphoprotein mapping, and electrophysiological correlations used by labs at Johns Hopkins University, University of Chicago, and University of Michigan. His conceptual advances on regulatory proteins and synaptic signaling intersected with molecular neurobiology programs at Duke University, University of California, San Diego, and University of Toronto, and informed drug discovery efforts at pharmaceutical centers like Pfizer and academic-industrial collaborations with Novartis and GlaxoSmithKline.

Awards and honors

Greengard received the Nobel Prize in Physiology or Medicine in 2000, an award he shared with colleagues whose work connected to neurotransmitter signaling and synaptic biology from institutions such as University of Cambridge and Max Planck Institute for Medical Research. He was honored with the Albert Lasker Basic Medical Research Award, the National Medal of Science, and international recognitions from bodies including the Royal Society and the National Academy of Sciences. He held memberships and fellowships in organizations like the American Academy of Arts and Sciences, Institute of Medicine (now the National Academy of Medicine), and received awards presented by entities such as The Rockefeller University and philanthropic foundations tied to biomedical research.

Academic and professional positions

Greengard served as a faculty member and laboratory head at Rockefeller University, where he directed research programs and mentored scientists who later took positions at institutions including MIT, Harvard Medical School, and Stanford University School of Medicine. Earlier appointments and associations included work connected to Columbia University and collaborative projects with researchers at Yale University, Johns Hopkins University, and Brandeis University. He participated in academic councils and advisory boards for organizations such as the National Institutes of Health, Howard Hughes Medical Institute, and international research consortia involving Karolinska Institute and Institut Pasteur.

Greengard’s trainees and collaborators went on to faculty roles at University of California, Berkeley, Cornell University, Brown University, University of Pennsylvania, and research institutions like Cold Spring Harbor Laboratory and Salk Institute for Biological Studies, extending his influence across biochemistry, pharmacology, and neuroscience networks.

Personal life and legacy

Outside the laboratory, Greengard engaged with cultural and scientific institutions in New York City and supported initiatives connected to Rockefeller University and medical centers like Mount Sinai Hospital and NewYork-Presbyterian Hospital. His family included relatives active in the arts and academia associated with institutions such as Bennington College and Princeton University. Greengard’s legacy persists in the work of neuroscientists at universities including University College London, University of Oxford, University of California, San Diego, and research centers like Salk Institute for Biological Studies and Max Planck Institutes, where signaling, synaptic regulation, and neuropharmacology remain active fields. He is remembered through awards, named lectureships, and the continued citation of his discoveries in studies at organizations such as the National Institutes of Health, World Health Organization, and biomedical programs across global universities.

Category:American neuroscientists Category:Nobel laureates in Physiology or Medicine Category:1925 births Category:2019 deaths